JAMDA
Volume 8, Issue 2 , Pages 80-82 , February 2007

Anemia: It’s All About Quality of Life

  • David R. Thomas, MD, FACP, AGSF, GSAF, CMD

      Affiliations

    • Corresponding Author InformationAddress correspondence to David R. Thomas, MD, FACP, AGSF, GSAF, CMD, Saint Louis University Medical Center, Division of Geriatric Medicine, 1402 S. Grand Blvd., Rm M238, St. Louis, MO 63104.

References 

  1. Winearls CG, Oliver DO, Pippard MJ, Reid C, Downing MR, Cotes PM. Effect of human erythropoietin derived from recombinant DNA on the anaemia of patients maintained by chronic haemodialysis. Lancet. 1986;2(8517):1175–1178
  2. Argawal A, Silver MR, Walczyk M, Liu W, Audhya P. Once-monthly darbepoetin alfa for maintaining hemoglobin levels in older patients with chronic kidney disease. J Am Med Dir Assoc. 2007;8:83–90
  3. Thomas DR. Anemia and quality of life: Unrecognized and undertreated. J Gerontol A Biol Sci Med Sci. 2004;59:238–241
  4. Stefanacci RG. Implications of Medicare Part D in CKD anemia treatment. J Am Med Dir Assoc. 2006;7(9 Suppl 1):S13–S16
  5. Kamenetz Y, Beloosesky Y, Zelter C, et al. Relationship between routine hematological parameters, serum IL-3, IL-6 and erythropoietin and mild anemia and degree of function in the elderly. Aging Clin Exp Res. 1998;10:32–38
  6. Dharmarajan TS, Norkus EP. Mild anemia and the risk of falls in older adults from nursing homes and the community. J Am Med Dir Assoc. 2004;5:395–400
  7. Dharmarajan TS, Avula S, Norkus EP. Anemia increases risk for falls in hospitalized older adults: an evaluation of falls in 362 hospitalized, ambulatory, long-term care, and community patients. J Am Med Dir Assoc. 2006;7:287–293
  8. Herndon JG, Helmick CG, Sattin RW, et al. Chronic medical conditions and risk of fall injury events at home in older adults. J Am Geriatr Soc. 1997;45:739–743
  9. Steinberg KE. Anemia and falls. [editorial] J Am Med Dir Assoc. 2006;7:327
  10. Di Fazio I, Franzoni S, Fisoni GB, Gatti S, Cornali C, Stofler PM. Predictive role of single disease and their combination on recovery of balance and gait in disabled elderly patients. J Am Med Dir Assoc. 2006;7:208–211
  11. Chaves P, Ashar T, Guralnik JM, et al. Looking at the relationship between hemoglobin concentration and previous mobility difficulty in older women: Should the criteria used to define anemia in older people be changed?. J Am Geriatr Soc. 2002;50:1257–1264
  12. Levin A, Singer J, Thompson CR, et al. Prevalent left ventricular hypertrophy in the predialysis population: Identifying opportunities for intervention. Am J Kidney Dis. 1996;27:347–354
  13. Wu WC, Rathore SS, Wang Y, et al. Blood transfusion in elderly patients with acute myocardial infarction. N Engl J Med. 2001;345:1230–1236
  14. Ezekowitz JA, McAlister FA, Armstrong PW. Anemia is common in heart failure and is associated with poor outcomes: insights from a cohort of 12,065 patients with new-onset heart failure. Circulation. 2003;107:223–225
  15. McClellan WM, Flanders WD, Langston RD, et al. Anemia and renal insufficiency are independent risk factors for death among patients with congestive heart failure admitted to community hospitals: a population-based study. J Am Soc Nephrol. 2002;13:1928–1936
  16. Milward EA, Grayson DA, Creasey H, Janu MR, Brooks WS, Broe GA. Evidence for association of anaemia with vascular dementia. Neuroreport. 1999;10:2377–2381
  17. Cella D. Factors influencing quality of life in cancer patients: Anemia and fatigue. Semin Oncol. 1998;25(3 Suppl 7):43–46
  18. Beusterien KM, Nissenson AR, Port FK, Kelly M, Steinwald B, Ware JE. The effects of recombinant human erythropoietin on functional health and well-being in chronic dialysis patients. J Am Soc Nephrol. 1996;7:763–773
  19. Tangalos EG, Hoggard JG, Murray AM, Thomas DR. Treatment of kidney disease and anemia in elderly, long-term care residents. J Am Med Dir Assoc. 2004;5(4 Suppl):H1–H6
  20. Drueke TB, Locatelli F, Clyne N, et al. CREATE Investigators (Normalization of hemoglobin level in patients with chronic kidney disease and anemia). N Engl J Med. 2006;355:2071–2084
  21. Singh AK, Szczech L, Tang KL, et al. CHOIR Investigators (Correction of anemia with epoetin alfa in chronic kidney disease). N Engl J Med. 2006;355:2085–2098
  22. Cody J, Daly C, Campbell M, et al. Recombinant human erythropoietin for chronic renal failure anaemia in pre-dialysis patients. Cochrane Database of Systematic Reviews. 2005;3:CD003266
  23. Agarwal AK. Practical approach to the diagnosis and treatment of anemia associated with CKD in elderly. J Am Med Dir Asssoc. 2006;7(9 Suppl 1):S7–S12
  24. Robinson BE. Epidemiology of chronic kidney disease and anemia. J Am Med Dir Assoc. 2006;7(9 Suppl 1):S3–S6
  25. Morley JE, Kim MJ, Haren MT, Kevorkian R, Banks WA. Frailty and the aging male. Aging Male. 2005;8:135–140
  26. Morley JE, Perry HM, Miller DK. Something about frailty. J Gerontol A Biol Sci Med Sci. 2002;57:M698–M704
  27. Rizzo JD, Lichtin AE, Woolf SH, et al. Use of epoetin in patients with cancer: evidence-based clinical practice guidelines of the American Society of Clinical Oncology and the American Society of Hematology. J Clin Oncol. 2002;20:4083–4107
  28. Kleinman KS, Schweitzer SU, Perdue ST, Bleifer KH, Abels RI. The use of recombinant human erythropoietin in the correction of anemia in predialysis patients and its effect on renal function: a double-blind, placebo-controlled trial. Am J Kidney Dis. 1989;14:486–495
  29. Roth D, Smith RD, Schulman G, et al. Effects of recombinant human erythropoietin on renal function in chronic renal failure predialysis patients. Am J Kidney Dis. 1994;24:777–784
  30. Ganguli A, Singh NP, Ahuja N. A comparative study of nandrolone decanoate and erythropoietin on albumin levels, quality of life, and progression of renal disease in Indian predialysis CKD patients. Nephrol Dial Transplant. 2003;18(Suppl 4):692
  31. Lim VS, DeGowin RL, Zavala D, et al. Recombinant human erythropoietin treatment in pre-dialysis patients: A double-blind placebo-controlled trial. Ann Intern Med. 1989;110:108–114
  32. Teehan BP. Double-blind, placebo-controlled study of the therapeutic use of recombinant human erythropoietin for anemia associated with chronic renal failure in predialysis patients. Am J Kidney Dis. 1991;18:50–59
  33. Clyne N, Jogestrand T. Effect of erythropoietin treatment on physical exercise capacity and on renal function in predialytic uremic patients. Nephron. 1992;60:390–396
  34. Perlman RL, Finkelstein FO, Liu L, et al. Quality of life in chronic kidney disease (CKD): a cross-sectional analysis in the Renal Research Institute-CKD study. Am J Kidney Dis. 2005;45:658–666
  35. Ross SD, Fahrbach K, Frame D, Scheye R, Connelly JE, Glaspy J. The effect of anemia treatment on selected health-related quality-of-life domains: A systematic review. Clin Ther. 2003;25:1786–1805
  36. Meta-analysis of the effects of epoetin alfa treatment on quality of life in anaemic cancer patients. Anonymous Curr Med Res Opin. 2005;(21 Suppl 2):S16–S18
  37. Chang J, Couture F, Young S, McWatters KL, Lau CY. Weekly epoetin alfa maintains hemoglobin, improves quality of life, and reduces transfusion in breast cancer patients receiving chemotherapy. J Clin Oncol. 2005;23:2597–2605
  38. Cella D, Kallich J, McDermott A, Xu X. The longitudinal relationship of hemoglobin, fatigue and quality of life in anemic cancer patients: results from five randomized clinical trials. Ann Oncol. 2004;15:979–986
  39. Bokemeyer C, Aapro MS, Courdi A, et al. EORTC guidelines for the use of erythropoietic proteins in anaemic patients with cancer. Eur J Cancer. 2004;40:2201–2216
  40. Valderrabano F. Quality of life benefits of early anemia treatment. Nephrol Dial Transplant. 2000;15(Suppl):23–28
  41. Quirt I, Robeson C, Lau CY, et al. Canadian Eprex Oncology Study Group (Epoetin alfa therapy increases hemoglobin levels and improves quality of life in patients with cancer-related anemia who are not receiving chemotherapy and patients with anemia who are receiving chemotherapy). J Clin Oncol. 2001;19:4126–4134
  42. Silverberg OS, Wexler D, Sheps D, et al. The effect of correction of mild anemia in severe, resistant congestive heart failure using subcutaneous erythropoietin and intravenous iron: a randomized controlled study. J Am Coll Cardiol. 2001;37:1775–1780
  43. Mancini DM, Katz SD, Lang CC, LaManca J, Hudaihed A, Androne AS. Effect of erythropoietin on exercise capacity in patients with moderate to severe chronic heart failure. Circulation. 2003;107:294–299
  44. Levin A, Singer J, Thompson CR, et al. Prevalent left ventricular hypertrophy in the predialysis population: Identifying opportunities for intervention. Am J Kidney Dis. 1996;27:347–354
  45. Saag MS, Bowers P, Leitz GJ, Levine AM Community HIV Anemia Management Protocol Sites (CHAMPS) Study Group Community HIV Anemia Management Protocol Sites (CHAMPS) Study Group. Once-weekly epoetin alfa improves quality of life and increases hemoglobin in anemic HIV+ patients. AIDS Res Hum Retroviruses. 2004;20:1037–1045
  46. Wilson A, Yu HT, Goodnough LT, Nissenson AR. Prevalence and outcomes of anemia in rheumatoid arthritis: a systematic review of the literature. Am J Med. 2004;116(Suppl 7A):50S–57S

 Conflict of interest statement for Dr. Thomas can be viewed on the JAMDA website at http://www.journals.elsevierhealth.com/periodicals/jmda/content/conflictsofinterest.

PII: S1525-8610(06)00627-X

doi: 10.1016/j.jamda.2006.12.025

JAMDA
Volume 8, Issue 2 , Pages 80-82 , February 2007

Article Tools